Roots Analysis has announced the addition of “RNA Sequencing Services Market, 2022-2035” report to its list of offerings.
Despite the various technological advancements in RNA sequencing, there are several existing challenges, including difficulty in the sequencing of large-sized genes, shortage of human resources, lack of tools for data manipulation and analysis, and high capital requirement. In order to overcome these challenges and obtain a high-quality output, the outsourcing of RNA sequencing is considered as a preferable option, among other alternatives, by the companies engaged in RNA sequencing.
To request a sample copy / brochure of this report, please visit
Key Market Insights
Currently, more than 70 companies claim to offer RNA sequencing services, globally
Nearly 70% of the RNA sequencing service providers have been established post 2000, most of these are located in North America (58%) followed by Europe (22%). Further this segment of the industry is dominated by presence of mid-sized players (51-1,000 employees), representing 44% of the total service providers.
Nearly 75% of the companies employ Illumina’s sequencing platform
Of these, nearly 20% players offer services related to small RNA sequencing, followed by those offering services for mRNA sequencing (19%). Further, more than 80% of players claim to offer turnaround time of less than two weeks for different types of RNA sequencing services.
Close to 1,050 grants have been awarded to support the research initiatives focused on RNA sequencing, since 2018
Grants worth USD 487 million have been awarded to various companies / organizations working in this domain. Close to 85% of the grants have been awarded for less than five years, out of which 15% grants were funded by the National Cancer Institute.
Over 340 patents related to RNA sequencing have been filed / granted, since 2018
Owing to the increase in research and development efforts by various industry and non-industry players engaged in this domain, close to 87% of patent applications have been filed post-2018. It is worth noting that 58% patents related to RNA sequencing were filed / granted in Asia Pacific, alone.
Presently, more than 85 NGS library preparation kits are available in market for RNA sequencing
Majority (75%) of the kits offer turnaround time of less than five hours, out of which 80% kits contain enzyme mix as components. Further, most of the kits (40%) use plasma as the starting material, followed by kits that use serum (34%) and saliva (8%) as input samples.
North America and Europe are anticipated to capture larger share (~70%) of the market by 2035
The market will be primarily driven by RNA sequencing for research purposes (93%). Further, clinics and hospitals are expected to occupy larger share (45%) of the overall market (in terms of service-based revenues), by 2035.
For additional details, please visit
You may also be interested in the following titles:
- Targeted protein degradation market, 2022-2035
- Cell Therapy Manufacturing Market, 2021-2030
- Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at firstname.lastname@example.org
+1 (415) 800 3415
+44 (122) 391 1091
Facebook - https://www.facebook.com/RootsAnalysis
Twitter - https://twitter.com/RootsAnalysis
Medium - https://medium.com/@RootsAnalysis